At the time of writing, Acrivon Therapeutics Inc [ACRV] stock is trading at $7.52, up 2.31%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ACRV shares have gain 15.69% over the last week, with a monthly amount drifted -9.07%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Acrivon Therapeutics Inc [NASDAQ: ACRV] stock has seen the most recent analyst activity on September 16, 2024, when Ladenburg Thalmann upgraded its rating to a Buy but kept the price target unchanged to $16 for it. Previously, Ladenburg Thalmann downgraded its rating to Neutral on April 29, 2024. On March 01, 2024, JMP Securities initiated with a Mkt Outperform rating and assigned a price target of $14 on the stock. Maxim Group initiated its recommendation with a Buy. Oppenheimer started tracking with a Outperform rating for this stock on June 02, 2023, and assigned it a price target of $25. In a note dated May 08, 2023, BMO Capital Markets initiated an Outperform rating and provided a target price of $25 on this stock.
For the past year, the stock price of Acrivon Therapeutics Inc fluctuated between $3.19 and $11.90. Currently, Wall Street analysts expect the stock to reach $21.83 within the next 12 months. Acrivon Therapeutics Inc [NASDAQ: ACRV] shares were valued at $7.52 at the most recent close of the market. An investor can expect a potential return of 190.29% based on the average ACRV price forecast.
Analyzing the ACRV fundamentals
Gross Profit Margin for this corporation currently stands at 0.7% with Operating Profit Margin at -45.27%, Pretax Profit Margin comes in at -40.86%, and Net Profit Margin reading is -40.86%. To continue investigating profitability, this company’s Return on Assets is posted at -0.36, Equity is -0.48 and Total Capital is -0.43.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.25 points at the first support level, and at 6.99 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.74, and for the 2nd resistance point, it is at 7.97.
Ratios To Look Out For
It is important to note that Acrivon Therapeutics Inc [NASDAQ:ACRV] has a current ratio of 12.75. In addition, the Quick Ratio stands at 12.75 and the Cash Ratio stands at 2.93.
Transactions by insiders
Recent insider trading involved PERCEPTIVE ADVISORS LLC, 10% Owner, that happened on Apr 11 ’24 when 2.35 million shares were purchased.
